CAS: 677007-74-8
Ref: IN-DA01V5CK
| 1g | 78.00 € | ||
| 5g | 154.00 € | ||
| 250mg | 41.00 € |
Estimated delivery in United States, on Thursday 23 Jan 2025
Avatrombopag maleate
CAS:677007-74-8
Avatrombopag (AKR-501/E5501) is an oral TPO receptor agonist for thrombocytopenia treatment, approved in 2018.
Formula:
C33H38Cl2N6O7S2
Color and Shape:
Liquid
Molecular weight:
765.72
Ref: TM-T68888
| 25mg | 1,418.00 € | ||
| 50mg | 1,846.00 € | ||
| 100mg | 2,331.00 € |
Estimated delivery in United States, on Thursday 30 Jan 2025
Avatrombopag Maleate
Controlled ProductCAS:677007-74-8
Formula:
C29H34Cl2N6O3S2·C4H4O4
Color and Shape:
Neat
Molecular weight:
765.72
Ref: TR-A819920
| 1g | 7,727.00 € |
Estimated delivery in United States, on Tuesday 4 Feb 2025
Avatrombopag maleate
CAS:677007-74-8
Avatrombopag maleate is a small molecule that activates platelets by binding to the beta-granule protein …
Formula:
C33H38Cl2N6O7S2
Purity:
Min. 95%
Molecular weight:
765.7 g/mol
Ref: 3D-CCB00774
| 1g | 1,243.00 € | ||
| 500mg | 820.00 € |
Estimated delivery in United States, on Thursday 6 Mar 2025
